Replies to post #90483 on Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

I agree. The hardest part is accepting the reality that maybe, just maybe, LM isn't what we all thought it was. It's a fair question and one we need to grapple with.

The market and BP are now clearly on the sidelines. Amgen leaving was kind of the nail in the coffin for me. Keeping this thing afloat at this point, without the help of big money, seems like a fools errand.

I hope tomorrow sheds at least some light on where and why we don't have a partner and what will be done now that Amgen is gone (who's paying for NEO?). It's not looking good.

[fbg0316]

Excellent summary. It's difficult to accept the platform may not be what we thought it was. It's easier to accept how poorly the compnay has been managed, because that can be changed (and it has been) but now it's becoming more apparent it's not just poor management but that the science and trial data has not been that impressive to Pharmas or investors and we can't change that, which is harder to swallow.